147 related articles for article (PubMed ID: 11260250)
1. Microdialysis of histamine in the skin of patients with mastocytosis.
Krogstad AL; Roupe G
Exp Dermatol; 2001 Apr; 10(2):118-23. PubMed ID: 11260250
[TBL] [Abstract][Full Text] [Related]
2. No relationship between histamine release measured as metabolite excretion in the urine, and serum levels of mast cell specific tryptase in mastocytosis.
Granerus G; Lönnqvist B; Roupe G
Agents Actions; 1994 Jun; 41 Spec No():C127-8. PubMed ID: 7526641
[TBL] [Abstract][Full Text] [Related]
3. Serum tryptase measured with B12 and G5 antibody-based immunoassays in mastocytosis patients and its relation to histamine turnover.
Granerus G; Lönnqvist B; Nystrand J; Roupe G
Br J Dermatol; 1998 Nov; 139(5):858-61. PubMed ID: 9892955
[TBL] [Abstract][Full Text] [Related]
4. Levels of mast-cell growth factors in plasma and in suction skin blister fluid in adults with mastocytosis: correlation with dermal mast-cell numbers and mast-cell tryptase.
Brockow K; Akin C; Huber M; Scott LM; Schwartz LB; Metcalfe DD
J Allergy Clin Immunol; 2002 Jan; 109(1):82-8. PubMed ID: 11799370
[TBL] [Abstract][Full Text] [Related]
5. Urinary 11β-PGF2α and N-methyl histamine correlate with bone marrow biopsy findings in mast cell disorders.
Divekar R; Butterfield J
Allergy; 2015 Oct; 70(10):1230-8. PubMed ID: 26095439
[TBL] [Abstract][Full Text] [Related]
6. Increased interstitial histamine concentration in the psoriatic plaque.
Krogstad AL; Lönnroth P; Larson G; Wallin BG
J Invest Dermatol; 1997 Nov; 109(5):632-5. PubMed ID: 9347790
[TBL] [Abstract][Full Text] [Related]
7. Mast cell tryptase in dermal neurogenic inflammation.
Schmelz M; Zeck S; Raithel M; Rukwied R
Clin Exp Allergy; 1999 May; 29(5):695-702. PubMed ID: 10231325
[TBL] [Abstract][Full Text] [Related]
8. Markers of mast cell degranulation.
Hogan AD; Schwartz LB
Methods; 1997 Sep; 13(1):43-52. PubMed ID: 9281467
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of mast cells in mastocytosis and inhibitory effect of ketotifen and ranitidine on indolent systemic mastocytosis.
Kurosawa M; Amano H; Kanbe N; Akimoto S; Takeuchi Y; Yamashita T; Hashimoto T; Kurimoto F; Miyachi Y
J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 2):S25-32. PubMed ID: 9440541
[TBL] [Abstract][Full Text] [Related]
10. In vitro functional reactivities of cutaneous mast cells from patients with mastocytosis.
Tharp MD; Chaker B; Glass MJ; Burton R; Seelig LL
J Invest Dermatol; 1987 Sep; 89(3):264-8. PubMed ID: 3624898
[TBL] [Abstract][Full Text] [Related]
11. [Systemic mastocytosis].
Fain O; Stirnemann J; Eclache V; Barete S; Casassus P; Hermine O; Lorholary O
Presse Med; 2005 May; 34(9):681-7. PubMed ID: 15988348
[TBL] [Abstract][Full Text] [Related]
12. Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease.
Sperr WR; Jordan JH; Fiegl M; Escribano L; Bellas C; Dirnhofer S; Semper H; Simonitsch-Klupp I; Horny HP; Valent P
Int Arch Allergy Immunol; 2002 Jun; 128(2):136-41. PubMed ID: 12065914
[TBL] [Abstract][Full Text] [Related]
13. Nerve-induced histamine release is of little importance in psoriatic skin.
Krogstad AL; Lönnroth P; Larson G; Wallin BG
Br J Dermatol; 1998 Sep; 139(3):403-9. PubMed ID: 9767283
[TBL] [Abstract][Full Text] [Related]
14. Studies on histamine metabolism in mastocytosis.
Granerus G; Olafsson JH; Roupe G
J Invest Dermatol; 1983 May; 80(5):410-6. PubMed ID: 6841997
[TBL] [Abstract][Full Text] [Related]
15. Nontryptase Urinary and Hematologic Biomarkers of Mast Cell Expansion and Mast Cell Activation: Status 2022.
Butterfield JH
J Allergy Clin Immunol Pract; 2022 Aug; 10(8):1974-1984. PubMed ID: 35346887
[TBL] [Abstract][Full Text] [Related]
16. Surrogate markers of disease in mastocytosis.
Akin C; Metcalfe DD
Int Arch Allergy Immunol; 2002 Feb; 127(2):133-6. PubMed ID: 11919423
[TBL] [Abstract][Full Text] [Related]
17. Rapid quantification of histamine in human psoriatic plaques using microdialysis and ultra high performance liquid chromatography with fluorescence detection.
Guihen E; Ho WL; Hogan AM; O'Connell ML; Leahy MJ; Ramsay B; O'Connor WT
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jan; 880(1):119-24. PubMed ID: 22177234
[TBL] [Abstract][Full Text] [Related]
18. Modulation of tryptase and histamine release from human lung mast cells by protease inhibitors.
He S; Xie H
Asian Pac J Allergy Immunol; 2004 Dec; 22(4):205-12. PubMed ID: 15783133
[TBL] [Abstract][Full Text] [Related]
19. Co-localization of tryptase and cathepsin-G in mast cells in cutaneous mastocytosis.
Ribatti D; Nico B; Finato N; Crivellato E; Beltrami CA
Cancer Lett; 2009 Jul; 279(2):209-12. PubMed ID: 19250736
[TBL] [Abstract][Full Text] [Related]
20. Opioid-induced mast cell activation and vascular responses is not mediated by mu-opioid receptors: an in vivo microdialysis study in human skin.
Blunk JA; Schmelz M; Zeck S; Skov P; Likar R; Koppert W
Anesth Analg; 2004 Feb; 98(2):364-370. PubMed ID: 14742371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
